Recent updates on the role of chemotherapy in pancreatic cancer

被引：34

作者：

Burris, HA

机构：

[1] Sarah Cannon Canc Ctr, Nashville, TN USA

[2] Tennessee Oncol PLLC, Nashville, TN USA

来源：

SEMINARS IN ONCOLOGY | 2005年 / 32卷 / 04期

关键词：

D O I：

10.1053/j.seminoncol.2005.06.022

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：S1 / S3

页数：3

相关论文

共 15 条

[1]

BERLIN J, 2001, P AN M AM SOC CLIN, V20, P127

[2] Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial [J].

Burris, HA ;

Moore, MJ ;

Andersen, J ;

Green, MR ;

Rothenberg, ML ;

Madiano, MR ;

Cripps, MC ;

Portenoy, RK ;

Storniolo, AM ;

Tarassoff, P ;

Nelson, R ;

Dorr, FA ;

Stephens, CD ;

VanHoff, DD .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) :2403-2413

[3]

Cheverton P, 2004, J CLIN ONCOL, V22, p314S

[4]

HEINEMANN V, 2003, P AN M AM SOC CLIN, V22, P250

[5]

Kindler HL, 2004, J CLIN ONCOL, V22, p315S

[6]

KINDLER HLL, 2004, CHEM FDN P NEW YORK, V24, P28

[7]

Louvet C, 2004, J CLIN ONCOL, V22, p315S

[8]

Maples WJ, 2004, J CLIN ONCOL, V22, p333S

[9]

MAPLES WJ, 2004, THALIDOMIDE GEMCITAB

[10]

Moore MJ, 2005, J CLIN ONCOL, V23, p1S